Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Astrocytoma 3Oligodendroglioma 2Glioma 2Central Nervous System Neoplasms 2Medulloblastoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Filgrastim 10Temozolomide 5Peripheral Blood Stem Cell Transplantation 5sargramostim 4Carboplatin 4Thiotepa 3Cyclophosphamide 3Busulfan 3Topotecan 2Radiotherapy 2Oxaliplatin 2Melphalan 2Irinotecan 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Cyproheptadine 2Cisplatin 2trioctyl phosphine oxide 1palbociclib 1olaparib 1ixabepilone 1ispinesib 1gallium Ga 68 dotatate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Genetic Therapy × Sarcoma × Clear all
NCT00005796 2015-03-25

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Indiana University

Phase 1 Completed
10 enrolled
CNSSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡